Standard Biotools (LAB) Amortizatization of Intangibles (2010 - 2026)
Standard Biotools (LAB) posted quarterly Amortizatization of Intangibles of $632000.0 for Q1 2026, down 24.85% year-over-year from $841000.0 in Q1 2025, and up 36.8% quarter-over-quarter from $462000.0 in Q4 2025.
Standard Biotools (LAB) Amortizatization of Intangibles (2010 - 2026) Analysis & Trends
Standard Biotools (LAB) has reported Amortizatization of Intangibles for 7 consecutive years, with $632000.0 the latest figure, recorded in Q1 2026.
- In Q1 2026, Amortizatization of Intangibles fell 24.85% year-over-year to $632000.0; the TTM figure through Mar 2026 stood at $2.4 million (down 56.64% YoY), while the FY2025 annual figure was $2.6 million, down 64.44% from the prior year.
- Amortizatization of Intangibles advanced to $632000.0 in Q1 2026 per LAB's latest filing, from $462000.0 in the prior quarter.
- Across five years, Amortizatization of Intangibles topped out at $2.7 million in Q1 2024 and bottomed at -$14000.0 in Q2 2023.
- Historically, Amortizatization of Intangibles has averaged $920923.1 across 4 years, with a median of $730000.0 in 2025.
- Annual changes were most pronounced in 2024 — Amortizatization of Intangibles soared 13557.14% — and 2025, when it plunged 68.38%.
- Standard Biotools' Amortizatization of Intangibles stood at $940000.0 in 2023, then advanced by 20.43% to $1.1 million in 2024, then tumbled by 59.19% to $462000.0 in 2025, then jumped by 36.8% to $632000.0 in 2026.
- Business Quant data shows LAB's Amortizatization of Intangibles at $632000.0 in Q1 2026, $462000.0 in Q4 2025, and $611000.0 in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Amortizatization of Intangibles (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 199.70 Bn | 194.10 Bn | 7.27 Bn | - |
| 2 | Stryker | 127.86 Bn | 124.38 Bn | 4.50 Bn | - |
| 3 | Medtronic | 119.05 Bn | 109.83 Bn | 6.41 Bn | - |
| 4 | Boston Scientific | 73.61 Bn | 73.07 Bn | 3.85 Bn | - |
| 5 | Edwards Lifesciences | 52.00 Bn | 47.75 Bn | 1.35 Bn | 6.60 Mn |
| 6 | Dexcom | 34.36 Bn | 32.42 Bn | 830.00 Mn | - |
| 7 | GE HealthCare Technologies | 33.85 Bn | 31.74 Bn | 2.18 Bn | - |
| 8 | Koninklijke Philips | 26.38 Bn | 23.06 Bn | 4.55 Bn | - |
| 9 | Steris | 23.08 Bn | 22.59 Bn | 684.20 Mn | - |
| 10 | Standard Biotools | 252.70 Mn | -224.01 Mn | 10.54 Mn | 1.25 Mn |
Historic Data
Download Data| Date | Value |
|---|---|
| Jun 30, 2026 | 1.21 Mn |
| Jun 30, 2026 | 1.21 Mn |
| Mar 31, 2026 | 632,000.00 |
| Mar 31, 2026 | 632,000.00 |
| Dec 31, 2025 | 462,000.00 |
| Dec 31, 2025 | 462,000.00 |
| Sep 30, 2025 | 611,000.00 |
| Sep 30, 2025 | 611,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Jun 30, 2025 | 730,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Mar 31, 2025 | 841,000.00 |
| Dec 31, 2024 | 1.13 Mn |
| Dec 31, 2024 | 1.13 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Sep 30, 2024 | 1.76 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Jun 30, 2024 | 1.88 Mn |
| Mar 31, 2024 | 2.66 Mn |
| Mar 31, 2024 | 2.66 Mn |